In the title compounds, C 24 H 22 BrN 3 , (I), and C 24 H 22 ClN 3 , (II), the 2-aminopyridine ring is fused with a cycloheptane ring, which adopts a half-chair conformation. The planes of the phenyl and benzene rings are inclined to that of the central pyridine ring [r.m.s. deviations = 0.0083 (1) and 0.0093 (1) Å for (I) and (II), respectively] by 62.47 (17) and 72.51 (14) , respectively, in (I), and by 71.44 (9) and 54.90 (8) , respectively, in (II). The planes of the aromatic rings are inclined to one another by 53.82 (17) in (I) and by 58.04 (9) in (II). In the crystals of both (I) and (II), pairs of N-HÁ Á ÁN nitrile hydrogen bonds link the molecules, forming inversion dimers with R 2 2 (12) ring motifs. In (I), the resulting dimers are connected through C-HÁ Á ÁBr hydrogen bonds, forming sheets parallel to (101), and -interactions [inter-centroid distance = 3.7821 (16) Å ] involving inversion-related pyridine rings, forming a three-dimensional network. In (II), the resulting dimers are connected through -interactions [intercentroid distance = 3.771 (2) Å ] involving inversion-related pyridine rings, forming a two-dimensional network lying parallel to (001).
Chemical context
The heterocyclic skeleton containing a nitrogen atom is the basis of many essential pharmaceuticals and of many physiologically active natural products. Molecules containing heterocyclic substructures continue to be attractive targets for synthesis since they often exhibit diverse and important biological properties. Pyridine is used in the pharmaceutical industry as a raw material for various drugs, vitamins and fungicides, and as a solvent (Shinkai et al., 2000; Jansen et al., 2001; Amr et al., 2006) . Pyridines are also omnipresent in medicaments and in agrochemicals (Tomlin, 1994) . Pyridine derivatives have occupied a unique position in medicinal chemistry. Among them, 2-amino-3-cyanopyridines have been identified as IKK-inhibitors (Murata et al., 2003) . Many fused cyanopyridines have also been shown to have a wide spectrum of biological activity (Boschelli et al., 2004) . Our interest in the preparation of pharmacologically active 3-cyanopyridine compounds led us to synthesize the title compounds and we report herein on their crystal structures. 
Structural commentary
The molecular structures of the title compounds, (I) and (II), are shown in Figs. 1 and 2, respectively. The bromo derivative (I), crystallizes in the monoclinic space group P2 1 /n while the chloro derivative (II), crystallizes in the triclinic space group P1.
In both compounds, the pyridine ring is connected to a benzene ring by a -CH 2 -NH 2 -chain, as found in a similar structure N 6 -(4-fluorobenzyl)-3-nitropyridine-2,6-diamine (Ge & Qian, 2011) . As expected, the pyridine ring (C2-C6/N3) is planar with r.m.s. deviations of 0.0083 and 0.0093 Å in compounds (I) and (II), respectively. In both compounds, the cycloheptane ring adopts a half-chair conformation, with puckering parameters Q2 = 0.415 (3) Å , '2 = 310.1 (4) and Q3 = 0.637 (3) Å and '3 = 283.4 (3) for compound (I) and Q2 = 0.475 (2) Å , '2 = 310.3 (2) and Q3 = 0.635 (2) Å and '3 = 283.58 (17) for compound (II). The amine N atom, N2, attached to the pyridine ring (N3/C2-C6) deviates by only 0.0107 (1) and 0.0073 (1) Å from the ring plane in (I) and (II), respectively. Steric hindrance rotates the benzene ring (C31-C36) out of the plane of the central pyridine ring by 72.51 (14) in compound (I) and by only 54.90 (8) in compound (II). The benzene ring is inclined to the phenyl ring (C22-C27) by 53.82 (17) in (I) and by 58.04 (9) in (II).
Supramolecular features
In the crystal of (I), molecules are linked by pairs of N-HÁ Á ÁN nitrile hydrogen bonds, forming inversion dimers with R 2 2 (12) ring motifs (Table 1 and Fig. 3 ). The resulting dimers are connected through C-HÁ Á ÁBr hydrogen bonds, forming sheets lying parallel to (101). The sheets are connected by weak -stacking interactions involving adjacent inversionrelated pyridine rings with a centroid-to-centroid distance of 3.7710 (7) Å , as shown in Fig. 3 . These interactions lead to the formation of a three-dimensional network.
In the crystal of (II), molecules are also linked by pairs of N-HÁ Á ÁN nitrile hydrogen bonds, forming inversion dimers with R 2 2 (12) ring motifs (Table 2 and Fig. 4) . The dimers are connected through weak -interactions involving inversionrelated pyridine rings with a centroid-to-centroid distance of Figure 1 The molecular structure of compound (I), showing 50% probability displacement ellipsoids and the atom labelling.
Figure 2
The molecular structure of (II), showing 50% probability displacement ellipsoids and the atom labelling. Table 1 Hydrogen-bond geometry (Å , ) for (I). 
Figure 3
Crystal packing diagram of compound (I), viewed along the b axis.
3.7818 (2) Å (Fig. 4) . The resulting structure is a two-dimensional network lying parallel to (001).
Synthesis and crystallization
Compounds (I) and (II) were prepared in a similar manner using 4-bromo aldehyde (1 mmol) for compound (I) and 4-chloro aldehyde (1 mmol) for compound (II). A mixture of cycloheptanone (1 mmol), aromatic aldehyde (1 mmol), malononitrile (1 mmol) and benzylamine (1mmol) were taken in ethanol (10 ml) to which p-TSA (p-toluenesulfonic acid) (1.0 mmol) was added. The reaction mixture was heated under reflux for 2-3 h. On completion of the reaction, verified by thin-layer chromatography (TLC), the mixture was poured into crushed ice and extracted with ethyl acetate. The excess solvent was removed under vacuum and the residue was subjected to column chromatography using a petroleum ether/ ethyl acetate mixture (97:3 v/v) as eluent to afford the pure products. Table 2 Hydrogen-bond geometry (Å , ) for (II).
Symmetry code: (i) Àx; Ày þ 1; Àz þ 1.
Figure 4
Crystal packing diagram of compound (II), viewed along the b axis. Hydrogen bonds (see Table 2 for details) and -interactions are shown as dashed lines (centroids are shown as small circles). H atoms not involved in hydrogen bonding have been omitted for clarity. 
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 3 . The NH and C-bound H atoms were placed in calculated positions and allowed to ride on their carrier atoms: N-H = 0.86 Å and C-H = 0.93-0.97 Å with U iso (H) = 1.5U eq (C) for methyl H atoms and = 1.2U eq (N,C) for other H atoms. For both compounds, data collection: APEX2 (Bruker, 2004 ); cell refinement: SAINT (Bruker, 2004) ; data reduction:
SAINT (Bruker, 2004 ); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2008) ; molecular graphics: PLATON (Spek, 2009) . Software used to prepare material for publication: SHELXL2014 (Sheldrick, 2008) for (I); SHELXL97 (Sheldrick, 2008) for (II).
(I) 2-Benzylamino-4-(4-bromophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile
Crystal data 120.0 (2) N2-C21-H21B 108.7 C4-C3-C2 119.0 (2) C22-C21-H21B 108.7 C4-C3-C31 124.1 (2) H21A-C21-H21B 107.6 C2-C3-C31 116.8 (2) C27-C22-C23 117.7 (3) C3-C4-C5 117.0 (2) C27-C22-C21 123.6 (3) C3-C4-C7 121.9 (2) C23-C22-C21 118.6 (3) C5-C4-C7 121.1 (2) C22-C23-C24 120.6 (4) N3-C5-C4 124.4 (2) C22-C23-H23 119.7 N3-C5-C11 114.6 (2) C24-C23-H23 119.7 C4-C5-C11 121.0 (2) C25-C24-C23 120.7 (4) N3-C6-N2 118.9 (2) C25-C24-H24 119.7 N3-C6-C2 120.4 (2) C23-C24-H24 119.7 N2-C6-C2 120.6 (2) C26-C25-C24 119.2 (4) C4-C7-C8 114.9 (2) C26-C25-H25 120.4 C4-C7-H7A
108.6 C24-C25-H25 120.4 C8-C7-H7A
108.6 C25-C26-C27 120.6 (4) C4-C7-H7B
108.6 C25-C26-H26 119.7 C8-C7-H7B
108.6 C27-C26-H26 119.7 H7A-C7-H7B 107.5 C22-C27-C26 121.2 (3)
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